Selling And Administration Expenses Zmiana Data
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Acorda Therapeutics USD 21.82M 689K 2023-06
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amarin USD 45.46M 5.5M 2023-09
Amgen USD 1.76B 424M 2023-12
Arrowhead Research USD 26.19M 595K 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Biogen USD 608.5M 179.7M 2023-12
Bluebird Bio USD 40.7M 354K 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Enanta Pharmaceuticals USD 13.8M 1.18M 2023-09
Esperion Therapeutics USD 33.24M 719K 2023-09
Galectin Therapeutics USD 1.43M 198K 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Incyte USD 293.86M 25.97M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Moderna USD 470M 28M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
PTC Therapeutics USD 76.29M 4.6M 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Intercept Pharmaceuticals Koszty Sprzedaży I Administracji - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.